# High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis

> **NCT00939549** · PHASE2 · WITHDRAWN · sponsor: **Johns Hopkins University**

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

- **DRUG:** Cyclophosphamide/Glatiramer acetate

## Key facts

- **NCT ID:** NCT00939549
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-11
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study revised to retrospective chart review
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00939549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00939549, "High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00939549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*